Indigo_Logo_RGB_small

Nuclear Receptor & In Vitro Toxicology Solutions™

Free Whitepaper

Xenobiotic, Bile Acid, and Cholesterol Transporters

The activity of uptake and efflux transporters is an important aspect of the pharmacokinetics and dynamics of drugs and is significant in drug-drug and drug-nutrient interactions. In this free whitepaper, learn more about xenobiotic metabolism and the molecular mechanisms that affect enzyme and transporter activity. Greater understanding of this activity may contribute to the predictability of drug-drug interactions and help to develop safer therapeutic regimens.

Download this informative resource today to learn more about xenobiotic, bile acid, and cholesterol transporters and support your own research.

Download this whitepaper today

This Whitepaper Will Discuss:

  • The significance of hepatic transport systems in drug design, bioavailability, and more
  • The function of xenobiotic, cholesterol, and bile acid drug transporters in the liver
  • The regulation of hepatic transporters by xenobiotic-activated transcription factors

Supplement your own research with detailed insights and an informative overview of hepatic transporters in this free whitepaper from INDIGO Biosciences.

Why Choose Us?

Get what you need from the world's largest portfolio of nuclear receptors

INDIGO has the largest portfolio of cell-based nuclear receptor assays in the world, helping you identify compounds with the highest selectivity and the lowest potential for unwanted effects and off-target responses. Our broad portfolio of nuclear receptors makes us the preferred source for single receptor or full-panel screenings. Whether for nuclear receptor or in vitro toxicology solutions, our intellectual property, ease of use, and quick turnarounds will get you to the next phase of discovery, faster.

Make confident decisions with clear results about your compounds

To empower confident decision-making throughout the discovery process, INDIGO’s technology generates clear single receptor or full-panel screening results, making for better interpretation and more accurate data. Employing a luminescence-based method and our proprietary CryoMite™ preservation process, we provide reproducible results lot to lot about the efficacy, potency, and selectivity of your compounds, plus comprehensive lab reports that include helpful graphics, summaries, and insights.

Be supported in your study with a committed team of experts

INDIGO is a leading provider of nuclear receptor and in vitro toxicology solutions, recognized for our focus on client support. Committed to accelerating the discovery process for you, our team goes the extra mile by offering complimentary study consults, designs, and research, and providing a comprehensive review of the results with you. As objective experts focused on your success, it’s our duty to ensure the results we provide inform assured next steps.

Save time and money with accelerated lab results and decisions

At INDIGO, our cell-based assay kits and services accelerate scientific decision-making by reducing time, cost, and risk associated with the discovery process. We know that time is money during discovery and aim to get you to the next phase faster or prevent unnecessary steps forward. For quick data and decisions, our kits deliver results in just 24 hours. And, beyond saving time, our kits and services also provide the most comprehensive data for your investment.

Screen your compounds using reliable science, platforms, and people

INDIGO provides a superior combination of expertise, kits, services, and support to leading through startup organizations, ranging from pharmaceutical companies and biotechs to university labs and CROs. Lab directors across the globe trust us for single receptor or full-panel screenings at every stage of discovery, leveraging our industry-leading platforms, knowledgeable people, and proprietary science.

About Us

INDIGO Biosciences, Inc. is a leading provider of nuclear receptor and in vitro toxicology solutions that accelerate scientific decision-making. We supplement the world’s largest portfolio of nuclear receptor kits and services and in vitro toxicology solutions with greater results readability, reproducibility, and faster turnaround times. Our solutions, plus supportive team and reliable science and platforms, aim to reduce the time, cost, and risk associated with the discovery process.